Back to Search
Start Over
Intervention trials for adults with bipolar disorder in low-income and lower-middle-income countries: A systematic review.
- Source :
-
Journal of Affective Disorders . Aug2022, Vol. 311, p256-266. 11p. - Publication Year :
- 2022
-
Abstract
- <bold>Background: </bold>The treatment gap for bipolar disorder is aggravated by economic inequality. Around half of the world's population live in a low-or lower-middle-income country, where research on treatment is scarce. Hence, this review aims to determine the number and types of intervention studies conducted on adults with bipolar disorder in low-income and lower-middle-income countries and analyze the effect of these interventions on symptom severity, medical adherence, and quality of life.<bold>Methods: </bold>A systematic review was conducted in June and November 2021 using eight databases. Controlled intervention trials on adults with bipolar disorder on data from low-income and lower-middle-income countries at time of publication were included. The risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials or The Risk Of Bias In Non-randomized Studies of Interventions assessment tool.<bold>Results: </bold>Twenty-one studies met the inclusion criteria. These were divided into four subtypes based on the intervention; pharmacotherapy (=12), psychosocial (=7), electroconvulsive therapy (=1), and traditional medicine (=1). Three studies were from low-income countries. A high risk of bias characterized the studies; only four studies reported the procedures used for randomization. Most studies, however, identified a beneficial effect on symptom severity, and in addition, medical adherence could be improved with psychosocial interventions.<bold>Limitations: </bold>Heterogeneity across studies prevented any meaningful pooling of data to meta-analyses.<bold>Conclusion: </bold>Data for treatment interventions contextualized to the local setting for bipolar disorder remains sparse, particularly from low-resource settings. Further studies are urgently needed to target the treatment gap for bipolar disorder.<bold>Trial Registration: </bold>PROSPERO: CRD42020170953. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01650327
- Volume :
- 311
- Database :
- Academic Search Index
- Journal :
- Journal of Affective Disorders
- Publication Type :
- Academic Journal
- Accession number :
- 157418281
- Full Text :
- https://doi.org/10.1016/j.jad.2022.05.097